🇺🇸 FDA
Patent

US 7863414

Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

granted A61KA61K38/45A61K38/50

Quick answer

US patent 7863414 (Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain) held by The Board of Regents of the University of Texas System expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/45, A61K38/50, A61P, A61P9/00